Sumitomo Life Insurance Co. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,966 shares of the company’s stock, valued at approximately $767,000.
Other large investors have also added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. grew its holdings in shares of HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares in the last quarter. Advisors Capital Management LLC grew its stake in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares in the last quarter. Liberty Wealth Management LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $1,905,000. Arrowstreet Capital Limited Partnership increased its stake in HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after acquiring an additional 245,887 shares during the last quarter. Finally, Sunbelt Securities Inc. lifted its stake in shares of HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after purchasing an additional 3,945 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.
Analysts Set New Price Targets
Several research firms recently weighed in on HCA. TD Cowen decreased their price target on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Truist Financial reduced their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th. Mizuho reduced their price objective on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 28th. Cantor Fitzgerald dropped their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Finally, Argus decreased their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $462.64.
HCA Healthcare Price Performance
HCA Healthcare stock opened at $429.08 on Friday. The stock has a market cap of $92.90 billion, a price-to-earnings ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. The firm has a 50-day moving average of $397.16 and a two-hundred day moving average of $444.14. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the previous year, the firm posted $6.84 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. Research analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
